Wordt geladen...
Addressing COVID‐19 Drug Development with Artificial Intelligence
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus that led to the COVID‐19 (Coronavirus Disease 2019) pandemic, has resulted in substantial overburdening of healthcare systems as well as an economic crisis on a global scale. This has in turn resulted in widespr...
Bewaard in:
| Gepubliceerd in: | Adv Intell Syst |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7235485/ https://ncbi.nlm.nih.gov/pubmed/32838299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/aisy.202000070 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|